• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-497和微小RNA-34a通过共同抑制细胞周期蛋白E1(CCNE1)来延缓肺癌生长。

miR-497 and miR-34a retard lung cancer growth by co-inhibiting cyclin E1 (CCNE1).

作者信息

Han Zhiyuan, Zhang Yanbin, Yang Qiaoyuan, Liu Binbin, Wu Jianjun, Zhang Yajie, Yang Chengfeng, Jiang Yiguo

机构信息

State Key Laboratory of Respiratory Disease, Institute for Chemical Carcinogenesis, Guangzhou Medical University, Guangzhou, P.R. China.

Department of Pulmonary Tuberculosis, Guangzhou Chest Hospital, Guangzhou, P.R. China.

出版信息

Oncotarget. 2015 May 30;6(15):13149-63. doi: 10.18632/oncotarget.3693.

DOI:10.18632/oncotarget.3693
PMID:25909221
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4537005/
Abstract

Cyclin E1, encoded by the CCNE1 gene, promotes G1/S transition, chromosome instability, and oncogenesis. Here, we show that miR-497 and miR-34a target the 3'-UTR of CCNE1. miR-497 and miR-34a are downregulated in cancer cells and their ectopic expression inhibited cell proliferation and colony formation in vitro, and inhibited tumor growth in a xenograft model. The effect of simultaneous overexpression of miR-497 and miR-34a on the inhibition of cell proliferation, colony formation, and tumor growth, and the downregulation of cyclin E1 was stronger than the effect of each miRNA alone. The synergistic actions of miR-497 and miR-34a partly correlated with cyclin E1 levels. When cells stably expressing CCNE1 were transfected with the Hi-miR-497/34a plasmid, there was no effect on colony formation, compared with that of cells transfected with either Hi-miR497 or Hi-miR34a. These results indicate cyclin E1 is downregulated by both miR-497 and miR-34a, which synergistically retard the growth of human lung cancer cells.

摘要

由CCNE1基因编码的细胞周期蛋白E1促进G1/S期转换、染色体不稳定和肿瘤发生。在此,我们表明miR-497和miR-34a靶向CCNE1的3'-UTR。miR-497和miR-34a在癌细胞中表达下调,其异位表达在体外抑制细胞增殖和集落形成,并在异种移植模型中抑制肿瘤生长。miR-497和miR-34a同时过表达对细胞增殖、集落形成和肿瘤生长的抑制作用以及细胞周期蛋白E1的下调作用比单独使用每种miRNA的作用更强。miR-497和miR-34a的协同作用部分与细胞周期蛋白E1水平相关。当用Hi-miR-497/34a质粒转染稳定表达CCNE1的细胞时,与用Hi-miR497或Hi-miR34a转染的细胞相比,对集落形成没有影响。这些结果表明细胞周期蛋白E1被miR-497和miR-34a下调,二者协同抑制人肺癌细胞的生长。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7e/4537005/05559dc7274c/oncotarget-06-13149-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7e/4537005/c6287e801e47/oncotarget-06-13149-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7e/4537005/1634cf4a6486/oncotarget-06-13149-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7e/4537005/434b98821e11/oncotarget-06-13149-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7e/4537005/69e9bef3d6b4/oncotarget-06-13149-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7e/4537005/91cc5117509e/oncotarget-06-13149-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7e/4537005/05559dc7274c/oncotarget-06-13149-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7e/4537005/c6287e801e47/oncotarget-06-13149-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7e/4537005/1634cf4a6486/oncotarget-06-13149-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7e/4537005/434b98821e11/oncotarget-06-13149-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7e/4537005/69e9bef3d6b4/oncotarget-06-13149-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7e/4537005/91cc5117509e/oncotarget-06-13149-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7e/4537005/05559dc7274c/oncotarget-06-13149-g006.jpg

相似文献

1
miR-497 and miR-34a retard lung cancer growth by co-inhibiting cyclin E1 (CCNE1).微小RNA-497和微小RNA-34a通过共同抑制细胞周期蛋白E1(CCNE1)来延缓肺癌生长。
Oncotarget. 2015 May 30;6(15):13149-63. doi: 10.18632/oncotarget.3693.
2
hsa-miR-CHA2, a novel microRNA, exhibits anticancer effects by suppressing cyclin E1 in human non-small cell lung cancer cells.hsa-miR-CHA2,一种新型 microRNA,通过抑制人非小细胞肺癌细胞中的 cyclin E1 发挥抗癌作用。
Biochim Biophys Acta Mol Basis Dis. 2024 Aug;1870(6):167250. doi: 10.1016/j.bbadis.2024.167250. Epub 2024 May 18.
3
MicroRNA-874-mediated inhibition of the major G/S phase cyclin, CCNE1, is lost in osteosarcomas.微小 RNA-874 介导的主要 G1/S 期周期蛋白 CCNE1 的抑制作用在骨肉瘤中丢失。
J Biol Chem. 2017 Dec 29;292(52):21264-21281. doi: 10.1074/jbc.M117.808287. Epub 2017 Nov 6.
4
MicroRNA-107 induces cell cycle arrests by directly targeting cyclin E1 in ovarian cancer.微小 RNA-107 通过直接靶向卵巢癌细胞周期蛋白 E1 诱导细胞周期停滞。
Biochem Biophys Res Commun. 2019 Apr 30;512(2):331-337. doi: 10.1016/j.bbrc.2019.03.009. Epub 2019 Mar 16.
5
[miR-497 suppresses proliferation of human cervical carcinoma HeLa cells by targeting cyclin E1].[微小RNA-497通过靶向细胞周期蛋白E1抑制人宫颈癌HeLa细胞增殖]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 Jun;30(6):597-600.
6
MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.miR-15a 在乳腺癌中低表达,并通过靶向 CCNE1 抑制细胞周期。
Int J Oncol. 2013 Oct;43(4):1212-8. doi: 10.3892/ijo.2013.2034. Epub 2013 Jul 23.
7
Defective Myb Function Ablates Cyclin E1 Expression and Perturbs Intestinal Carcinogenesis.Myb功能缺陷消除细胞周期蛋白E1表达并扰乱肠道癌变过程。
Mol Cancer Res. 2015 Aug;13(8):1185-96. doi: 10.1158/1541-7786.MCR-15-0014. Epub 2015 May 1.
8
Down-regulation of cyclin E1 expression by microRNA-195 accounts for interferon-β-induced inhibition of hepatic stellate cell proliferation.microRNA-195 通过下调 cyclin E1 的表达抑制肝星状细胞增殖。
J Cell Physiol. 2011 Oct;226(10):2535-42. doi: 10.1002/jcp.22598.
9
A novel long non-coding RNA LINC00355 promotes proliferation of lung adenocarcinoma cells by down-regulating miR-195 and up-regulating the expression of CCNE1.一种新型长非编码 RNA LINC00355 通过下调 miR-195 和上调 CCNE1 的表达促进肺腺癌细胞的增殖。
Cell Signal. 2020 Feb;66:109462. doi: 10.1016/j.cellsig.2019.109462. Epub 2019 Nov 2.
10
MicroRNA-7 arrests cell cycle in G1 phase by directly targeting CCNE1 in human hepatocellular carcinoma cells.MicroRNA-7 通过直接靶向人肝癌细胞中的 CCNE1 使细胞周期停滞在 G1 期。
Biochem Biophys Res Commun. 2014 Jan 17;443(3):1078-84. doi: 10.1016/j.bbrc.2013.12.095. Epub 2013 Dec 25.

引用本文的文献

1
MicroRNA Expression Analysis and Biological Pathways in Chemoresistant Non-Small Cell Lung Cancer.化疗耐药非小细胞肺癌中的微小RNA表达分析及生物学通路
Cancers (Basel). 2025 Jul 29;17(15):2504. doi: 10.3390/cancers17152504.
2
High Glucose-Induced Senescent Fibroblasts-Derived Exosomal miR-497 Inhibits Wound Healing by Regulating Endothelial Cellular Autophagy via ATG13.高糖诱导的衰老成纤维细胞衍生的外泌体miR-497通过ATG13调节内皮细胞自噬来抑制伤口愈合。
Anal Cell Pathol (Amst). 2025 Jan 11;2025:8890200. doi: 10.1155/ancp/8890200. eCollection 2025.
3
Constructing lncRNA-miRNA-mRNA networks specific to individual cancer patients and finding prognostic biomarkers.

本文引用的文献

1
Cyclin E1 and RTK/RAS signaling drive CDK inhibitor resistance via activation of E2F and ETS.细胞周期蛋白E1和RTK/RAS信号通路通过激活E2F和ETS驱动细胞周期蛋白依赖性激酶抑制剂耐药。
Oncotarget. 2015 Jan 20;6(2):696-714. doi: 10.18632/oncotarget.2673.
2
MicroRNA-34a inhibits the proliferation and promotes the apoptosis of non-small cell lung cancer H1299 cell line by targeting TGFβR2.微小RNA-34a通过靶向转化生长因子β受体2(TGFβR2)抑制非小细胞肺癌H1299细胞系的增殖并促进其凋亡。
Tumour Biol. 2015 Apr;36(4):2481-90. doi: 10.1007/s13277-014-2861-5. Epub 2014 Dec 13.
3
Expression of miRNAs in non-small-cell lung carcinomas and their association with clinicopathological features.
构建特定于个体癌症患者的 lncRNA-miRNA-mRNA 网络,并寻找预后生物标志物。
BMC Genom Data. 2024 Jul 8;25(Suppl 1):67. doi: 10.1186/s12863-024-01251-9.
4
The microRNA-34 Family and Its Functional Role in Lung Cancer.miRNA-34 家族及其在肺癌中的功能作用。
Am J Clin Oncol. 2024 Sep 1;47(9):448-457. doi: 10.1097/COC.0000000000001106. Epub 2024 May 3.
5
Bone marrow microRNA-34a is a good indicator for response to treatment in acute myeloid leukemia.骨髓 microRNA-34a 是急性髓细胞白血病治疗反应的良好指标。
Oncol Res. 2024 Feb 6;32(3):577-584. doi: 10.32604/or.2023.043026. eCollection 2024.
6
Exosomal microRNA Therapy for Non-Small-Cell Lung Cancer.外泌体 microRNA 治疗非小细胞肺癌。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231210731. doi: 10.1177/15330338231210731.
7
CRISPR/Cas9-mediated inactivation of miR-34a and miR-34b/c in HCT116 colorectal cancer cells: comprehensive characterization after exposure to 5-FU reveals EMT and autophagy as key processes regulated by miR-34.CRISPR/Cas9 介导的 miR-34a 和 miR-34b/c 在 HCT116 结直肠癌细胞中的失活:5-FU 暴露后的综合表征揭示 EMT 和自噬是 miR-34 调控的关键过程。
Cell Death Differ. 2023 Aug;30(8):2017-2034. doi: 10.1038/s41418-023-01193-2. Epub 2023 Jul 24.
8
Lung microRNAs Expression in Lung Cancer and COPD: A Preliminary Study.肺癌和慢性阻塞性肺疾病中肺组织微小RNA的表达:一项初步研究
Biomedicines. 2023 Feb 28;11(3):736. doi: 10.3390/biomedicines11030736.
9
miR-125-3p and miR-276b-3p Regulate the Spermatogenesis of by Targeting the .miR-125-3p 和 miR-276b-3p 通过靶向 调控 的精子发生。
Genes (Basel). 2022 Oct 15;13(10):1861. doi: 10.3390/genes13101861.
10
Single Shot vs. Cocktail: A Comparison of Mono- and Combinative Application of miRNA-Targeted Mesyl Oligonucleotides for Efficient Antitumor Therapy.单次注射与联合用药:用于高效抗肿瘤治疗的miRNA靶向甲磺酰寡核苷酸单药与联合应用的比较
Cancers (Basel). 2022 Sep 9;14(18):4396. doi: 10.3390/cancers14184396.
微小RNA在非小细胞肺癌中的表达及其与临床病理特征的关联。
Tumour Biol. 2015 Mar;36(3):1603-12. doi: 10.1007/s13277-014-2755-6. Epub 2014 Nov 11.
4
miR-34: from bench to bedside.微小RNA-34:从实验室到临床应用
Oncotarget. 2014 Feb 28;5(4):872-81. doi: 10.18632/oncotarget.1825.
5
A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression.p53 和 miR-34 微 RNA 之间的正反馈介导肿瘤抑制。
Genes Dev. 2014 Mar 1;28(5):438-50. doi: 10.1101/gad.233585.113. Epub 2014 Feb 14.
6
Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness.p53对c-Kit的抑制作用由miR-34介导,且与化疗耐药性降低、迁移能力及干性相关。
Oncotarget. 2013 Sep;4(9):1399-415. doi: 10.18632/oncotarget.1202.
7
Downregulation of miR-497 promotes tumor growth and angiogenesis by targeting HDGF in non-small cell lung cancer.下调 miR-497 通过靶向调控 HDGF 促进非小细胞肺癌的肿瘤生长和血管生成。
Biochem Biophys Res Commun. 2013 Jun 7;435(3):466-71. doi: 10.1016/j.bbrc.2013.05.010. Epub 2013 May 11.
8
The tumor-suppressive miR-497-195 cluster targets multiple cell-cycle regulators in hepatocellular carcinoma.抑癌 miR-497-195 簇在肝细胞癌中靶向多个细胞周期调节剂。
PLoS One. 2013;8(3):e60155. doi: 10.1371/journal.pone.0060155. Epub 2013 Mar 27.
9
Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence.合成 miR-34a 模拟物作为多发性骨髓瘤的新型治疗剂:体外和体内证据。
Clin Cancer Res. 2012 Nov 15;18(22):6260-70. doi: 10.1158/1078-0432.CCR-12-1708. Epub 2012 Oct 3.
10
Regulation of human lung alveolar multipotent cells by a novel p38α MAPK/miR-17-92 axis.新型 p38α MAPK/miR-17-92 轴调控人肺肺泡多能细胞。
EMBO J. 2012 Aug 15;31(16):3431-41. doi: 10.1038/emboj.2012.192. Epub 2012 Jul 24.